Clinical presentation and pharmacological therapy in corticobasal degeneration

Archives of Neurology

Volumn 55, Issue 7, 1998, Pages 957-961

  Kompoliti, K ^a   Goetz, C G ^a   Boeve, B F ^b   Maraganore, D M ^b   Ahlskog, J E ^b   Marsden, C D ^c   Bhatia, K P ^c   Greene, P E ^d   Przedborski, S ^d   Seal, E C ^e   Burns, R S ^e   Hauser, R A ^f   Gauger, L L ^f   Factor, S A ^g   Molho, E S ^g   Riley, D E ^h  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g ALBANY MEDICAL COLLEGE   (United States)

^h Mt Sinai Medical Center Cleveland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; BROMOCRIPTINE; CARBIDOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; LEVODOPA; NEUROLEPTIC AGENT; PERGOLIDE MESILATE; PROPRANOLOL; SELEGILINE;

ARTICLE; AUTOPSY; BRADYKINESIA; BRAIN DEGENERATION; CLINICAL TRIAL; CONFUSION; DRUG EFFICACY; DYSTONIA; FEMALE; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MULTICENTER STUDY; MYOCLONUS; PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; SOMNOLENCE; TREATMENT OUTCOME; TREMOR; VERTIGO; XEROSTOMIA;

ANTIPARKINSON AGENTS; CEREBRAL CORTEX; HUMANS; LONDON; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; UNITED STATES;

EID: 0007910193     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.7.957     Document Type: Article

References (29)

1. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968;18:20-33.
2. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans Am Neurol Assoc. 1967;92:23-26.
3. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW. Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging. 1996;6:222-226.
4. Feany MB, Ksiezak-Reding H, Liu WK, Vincent I, Yen SH, Dickson DW. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy. Acta Neuropathol (Berl). 1995;90:37-43.
5. Feany MB, Dickson DW. Widespread cytoskeletal pathology characterizes corticobasal degeneration. Am J Pathol. 1995;146:1388-1396.
6. Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol. 1996;55:53-67.
7. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain. 1989;112: 1171-1192.
8. Gibb WR, Luthert PJ, Marsden CD. Clinical and pathological features of corticobasal degeneration. Adv Neurol. 1990;53:51-54.
9. Gimenez-Roldan S, Mateo D, Benito C, Grandas F, Perez-Gilabert Y. Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. J Neural Transm Suppl. 1994; 42:79-90.
10. Greene PE, Fahn S, Lang AE, Watts RL, Eidelberg D, Powers JM. What is it? case 1,1990: progressive unilateral rigidity, bradykinesia, tremulousness, and apraxia, leading to fixed postural deformity of the involved limb. Mov Disord. 1990;5: 341-351.
11. Eidelberg D, Dhawan V, Moeller JR, et al. The metabolic landscape of corticobasal ganglionic degeneration: regional asymmetries studied with positron emission tomography. J Neurol Neurosurg Psychiatry. 1991;54:856-862.
12. Dickson DW, Yen SH, Suzuki KI, Davies P, Garcia JH, Hirano A. Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (Berl). 1986;71:216-223.
13. Brunt ER, van Weerden TW, Pruim J, Lakke JW. Unique myoclonic pattern in corticobasal degeneration. Mov Disord. 1995;10:132-142.
14. Jendroska K, Rossor MN, Mathias CJ, Daniel SE. Morphological overlap between corticobasal degeneration and Pick's disease: a clinicopathological report. Mov Disord. 1995;10:111-114.
15. Lang AE, Bergeron C, Pollanen MS, Ashby P. Parietal Pick's disease mimicking cortical-basal ganglionic degeneration. Neurology. 1994;44:1436-1440.
16. Lippa CF, Smith TW, Fontneau N. Corticonigral degeneration with neuronal achromasia: a clinicopathologic study of two cases. J Neurol Sci. 1990;98: 301-310.
17. Mori H, Nishimura M, Namba Y, Oda M. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Acta Neuropathol (Berl). 1994;88: 113-121.
18. Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and AIz-beimer's disease. Neurology. 1995;45:1477-1483.
19. Paulus W, Selim M. Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles. Acta Neuropathol (Berl). 1990;81:89-94.
20. Riley DE, Lang AE, Lewis A, et al. Cortical-basal ganglionic degeneration. Neurology. 1990;40:1203-1212.
21. Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain. 1994;117:1183-1196.
22. Rey GJ, Tomer R, Levin BE, Sanchez-Ramos J, Bowen B, Bruce JH. Psychiatric symptoms, atypical dementia, and left visual field inattention in corticobasal ganglionic degeneration. Mov Disord. 1995;10:106-110.
23. Sawle GV, Brooks DJ, Marsden CD, Frackowiak RS. Corticobasal degeneration: a unique pattern of regional cortical oxygen hypometabolism and striatal fluorodopa uptake demonstrated by positron emission tomography. Brain. 1991; 114:541-556.
24. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol. 1994;35:420-426.
25. Rajput AH, Rozdilsky B, Ang L. Occurrence of resting tremor in Parkinson's disease. Neurology. 1991;41:1298-1299.
26. Goetz CG, Litvan I, Stebbins GT, et al. The accuracy of clinical signs in separating autopsy-proven corticobasal ganglionic degeneration from Parkinson's disease: positive and negative predictive value analysis [abstract]. Neurology. 1996; 46(suppl):A260-A261.
27. Litvan I, Agid Y, Goetz CG, et al. Validity of clinical diagnosis of corticobasal ganglionic degeneration. Mov Disord. 1996;11:354-355.
28. Boeve BF, Maraganore DM, Parisi JE, et al. Disorders mimicking the "classical" clinical syndrome of cortico-basal ganglionic degeneration: report of nine cases [abstract]. Mov Disord. 1996;11:351.
29. Maraganore DM, Ahlskog JE, Petersen RC. Progressive asymmetric rigidity with apraxia: a distinctive clinical entity [abstract], Mov Disord. 1992;7:80.